Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
The American Journal of Surgical Pathology|April 23, 2026
Hidradenoma in Axillary Lymph Nodes: A Diagnostic Pitfall Mimicking Metastatic CarcinomaGregory R Bean, Leandra G Kingsley, Jennifer Tan, et al.
Histopathology|November 1, 2018
CRTC1-MAML2 fusion in mucoepidermoid carcinoma of the breastGregory R Bean, Gregor Krings, Christopher N Otis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 4, 2020
Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesisFrancisco Beca, Gregor Krings, Yunn-Yi Chen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 4, 2023
Triple-Negative Apocrine Carcinomas: Toward a Unified Group With Shared Molecular Features and Clinical BehaviorChristopher J Schwartz, Jeanette Ruiz, Gregory R Bean, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 3, 2023
Solid-Basaloid Adenoid Cystic Carcinoma of the Breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB OverexpressionEliah R Shamir, Gregory R Bean, Christopher J Schwartz, et al.
Nature Medicine|March 8, 2016
Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancerRoman Camarda, Alicia Y Zhou, Rebecca A Kohnz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2021
Inflammation Mediates the Development of Aggressive Breast Cancer Following RadiotherapyLin Ma, Alba Gonzalez-Junca, Yufei Zheng, et al.
The Journal of Pathology|January 29, 2019
Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinomaNancy M Joseph, Christos G Tsokos, Sarah E Umetsu, et al.
NPJ Breast Cancer|May 26, 2021
Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injectionAlexa C Glencer, Jasmine M Wong, Nola M Hylton, et al.
Pageof 8